NEW YORK (AP) — Chunky bootmaker Dr. Martens is warning of a tough year ahead.
Dr. Martens shares plunged more than 30% Tuesday after the iconic British brand forecast wholesale revenue in the U.S., its largest market, would decline by double-digits compared with last year.
Trading in Dr. Martens stock was temporarily halted on the London Stock Exchange early Tuesday as it sank to a record-low 0.64 pounds, according to FactSet.
That could translate into a sizeable hit to profits, with the company pointing to a base projected impact of 20 million pounds ($24.9 million) on pretax earnings year-over-year. In-season orders from wholesale customers could help ease U.S. revenue expectations, the company noted, but those are difficult to predict.
Scottie Scheffler's Louisville court date postponed after arrest during PGA Championship
World Insights: NATO's meddling in Asia
IAEA board to hold meeting over Zaporizhzhia attacks
Australia, New Zealand send planes to evacuate nationals from New Caledonia
China's gross marine product exceeds 9 trillion yuan in 2023
UN chief calls for reaching consensus on climate actions at COP27
Harbin to Moscow freight train delivers vehicles to Russia
Nigella Lawson, 64, reveals she would 'never take Ozempic' as a weight
Rescue underway after earthquake hits Syria
China's first intelligent offshore drilling platform installed
Trojan horse or unproven fears? Into U.S. demonization of Chinese manufacturing